Publications:

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.

Embo Molecular Medicine

Zhang, Lianghui L; Narayanan, Krishna K KK; Cooper, Laura L; Chan, Kui K KK; Skeeters, Savanna S SS; Devlin, Christine A CA; Aguhob, Aaron A; Shirley, Kristie K; Rong, Lijun L; Rehman, Jalees J; Malik, Asrar B AB; Procko, Erik E

Publication Date: 2022-11-08

Variant appearance in text: ALK: N764K

PubMed Link: 36094679

Variant Present in the following documents:

• EMMM-9999-0-s003.pdf
• EMMM-9999-0.pdf

View BVdb publication page

An engineered ACE2 decoy receptor can be administered by inhalation and potently targets the BA.1 and BA.2 omicron variants of SARS-CoV-2.

Biorxiv : The Preprint Server For Biology

Zhang, Lianghui L; Narayanan, Krishna K KK; Cooper, Laura L; Chan, Kui K KK; Devlin, Christine A CA; Aguhob, Aaron A; Shirley, Kristie K; Rong, Lijun L; Rehman, Jalees J; Malik, Asrar B AB; Procko, Erik E

Publication Date: 2022-03-28

Variant appearance in text: ALK: N764K

PubMed Link: 35378764

Variant Present in the following documents:

• nihpp-2022.03.28.486075v1.pdf

View BVdb publication page